Clinical trial
Comparison of the Safety and Aesthetic Outcomes of a Novel Endoscopic-Assisted Breast-Conserving Surgery (SRRSHzb-EABCS) With Those of Conventional Breast-Conserving Surgery
NCT07920094 is registered in ClinicalTrials.gov with Sir Run Run Shaw Hospital as lead sponsor.
Follow this trial by email Email me the PDF
Summary
Recruiting, started July 2023. Interventional study, 422 participants (estimated). Lead sponsor Sir Run Run Shaw Hospital; China. Primary measure: Intraoperative and Postoperative Positive Margin Rate. 3 linked papers (newest 2021).
How it compares
4,055 similar trials: same condition (Breast Neoplasms) and phase
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Safety and Aesthetic Outcomes of a Novel Endoscopic-Assisted Breast-Conserving Surgery (SRRSHzb-EABCS) With Those of Conventional Breast-Conserving Surgery
- Lead sponsor
- Sir Run Run Shaw Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 1, 2023
- Completion date
- December 31, 2033
- Enrollment
- 422 (estimated)
- Sites
- 22
Conditions
MeSH condition names; the registry's own terms follow.
Registry terms: breast cancer
Who could take part, where it ran, who ran it
As filed in ClinicalTrials.gov.
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
- Healthy volunteers
- No
- Study type
- Interventional
- Sites
- 22
- Countries
- China
- Lead sponsor
- Sir Run Run Shaw Hospital
Arms
As registered; 2 arms.
| Arm | Type | Interventions |
|---|---|---|
| SRRSHzb-EABCS group | Experimental | Endoscopy-assisted breast-conserving surgery (SRRSHzb-EABCS) |
Show registry wordingParticipants undergo the novel endoscopy-assisted breast-conserving surgery SRRSHzb-EABCS, which uses a gasless expansion-traction endoscopic system with two custom-built instruments (a skin flap dissector and a V-shaped retractor) and percutaneously placed U-shaped metal wires for tumor localization and margin control. Through a single 3.0-4.5 cm axillary incision, the retromammary space and subcutaneous flap are created, and each U-shaped cutting wire is connected to an electrocautery pencil and energized to cut precisely along the planned resection margin under endoscopic vision ("hot-wire" cutting). Specimen margins are assessed by intraoperative frozen section; if a margin is positive, local re-excision of the margin is performed, and if margins remain repeatedly positive, mastectomy is performed. The defect is reconstructed with a pedicled glandular flap using volume displacement oncoplastic technique. | ||
| Conventional breast-conserving surgery (CBCS) group | Active comparator | Conventional open breast-conserving surgery (CBCS) |
Show registry wordingParticipants undergo conventional open breast-conserving surgery performed according to the Chinese Anti-Cancer Association guidelines for breast-conserving therapy, generally through separate breast and axillary incisions. The resection includes the tumor with surrounding breast tissue; specimen margins are marked and assessed (margin inking and/or intraoperative frozen section and imprint cytology); 4-6 titanium clips are placed in the tumor bed; and oncoplastic volume displacement or replacement techniques are used when needed. If a margin is positive on intraoperative or postoperative pathology, local re-excision of the margin is performed, and if margins remain repeatedly positive, mastectomy is performed. | ||
Primary endpoints
Registered primary outcome measures; 1 primary.
| Measure | Time frame |
|---|---|
| Intraoperative and Postoperative Positive Margin Rate | Intraoperatively and up to 1 month after surgery (final pathology report) |
Show registry wordingProportion of participants with positive resection margins of the breast-conserving specimen, including the first and any subsequent positive margins on intraoperative frozen section assessment and the positive margin rate on postoperative routine paraffin pathology. | |
Papers
PubMed papers this trial cites; 3 papers, results papers first, then newest first.
Lead sponsor's other trials
Sir Run Run Shaw Hospital, most recent start first.
+129 more trials See the organization page
Similar trials
Same condition (Breast Neoplasms) and phase, most recent start first.
+4,050 more trials See the condition page